Univariate and multivariate analyses of disease-free survival for breast cancer
Variables | Item | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|---|
Hazard rate ratio | 95% CI | P | Hazard rate ratio | 95% CI | P | ||
Stage | III/IV | 5.33 | 2.25–12.62 | <0.001 | 6.08 | 1.83–20.18 | 0.003 |
I/II | 1.00 | 1.00 | |||||
Grade | III | 1.38 | 0.55–3.42 | 0.491 | 1.10 | 0.39–3.05 | 0.862 |
I/II | 1.00 | 1.00 | |||||
Age, y | 50 | 4.27 | 1.56–11.66 | 0.005 | 2.19 | 0.73–6.56 | 0.163 |
≤50 | 1.00 | 1.00 | |||||
BMI, kg/m2 | <24 | 1.79 | 0.76–4.22 | 0.183 | 1.54 | 0.59–4.04 | 0.377 |
≥24 | 1.00 | 1.00 | |||||
ER | Negative | 2.45 | 1.04–5.77 | 0.041 | 0.69 | 0.12–3.94 | 0.674 |
Positive | 1.00 | 1.00 | |||||
PR | Negative | 1.99 | 0.84–4.72 | 0.120 | 3.76 | 0.74–19.15 | 0.111 |
Positive | 1.00 | 1.00 | |||||
Her2/neu | Positive | 0.70 | 0.27–1.80 | 0.455 | 0.64 | 0.22–1.87 | 0.413 |
Negative | 1.00 | 1.00 | |||||
Radiotherapy | Yes | 0.69 | 0.29–1.62 | 0.393 | 1.03 | 0.37–2.92 | 0.951 |
No | 1.00 | 1.00 | |||||
Chemotherapy | Yes | 1.45 | 0.43–4.91 | 0.555 | 0.88 | 0.23–3.41 | 0.848 |
No | 1.00 | 1.00 | |||||
Hormone therapy | Yes | 0.18 | 0.07–0.47 | <0.001 | 0.44 | 0.11–1.76 | 0.247 |
No | 1.00 | 1.00 | |||||
Visfatin | High | 5.73 | 1.92–17.14 | 0.002 | 4.11 | 1.15–14.70 | 0.030 |
Low | 1.00 | 1.00 |